Peer-to-peer injection: Demographic, drug use, and injection-related risk factors

Aceijas, 2007, Global estimates of prevalence of HCV infection among injecting drug users, International Journal on Drug Policy, 18, 352, 10.1016/j.drugpo.2007.04.004 Aceijas, 2004, Global overview of injecting drug use and HIV infection among injecting drug users, AIDS, 18, 2295, 10.1097/00002030-200411190-00010 Bluthenthal, 1995, Multimethod research from targeted sampling to HIV risk environments, NIDA Research Monograph, 157, 212 Booth, 2013, Law enforcement practices associated with HIV infection among injection drug users in Odessa, Ukraine, AIDS and Behavior, 17, 2604, 10.1007/s10461-013-0500-6 Bruneau, 2012, The rising prevalence of prescription opioid injection and its association with hepatitis C incidence among street-drug users, Addiction, 107, 1318, 10.1111/j.1360-0443.2012.03803.x Cagle, 2002 Callon, 2013, ‘On the same level’: Facilitators’ experiences running a drug user-led safer injecting education campaign, Harm Reduction Journal, 10, 4, 10.1186/1477-7517-10-4 Carlson, 2000, Shooting galleries, dope houses, and injection doctors: Examining the social ecology of HIV risk behaviors among drug injectors in Dayton, Ohio, Human Organization, 59, 325, 10.17730/humo.59.3.w483t11p717473k6 Cheng, 2016, High prevalence of assisted injection among street-involved youth in a Canadian setting, AIDS and Behavior, 20, 377, 10.1007/s10461-015-1101-3 Corsi, 2012, The feasibility of interventions to reduce HIV risk and drug use among heterosexual methamphetamine users, Journal of AIDS and Clinical Research, S1 Davidson, 2017, Using drugs in un/safe spaces: Impact of perceived illegality on an underground supervised injecting facility in the United States, International Journal on Drug Policy, 53, 37, 10.1016/j.drugpo.2017.12.005 Degenhardt, 2017, Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: A multistage systematic review, Lancet Global Health, 5, e1192, 10.1016/S2214-109X(17)30375-3 Des Jarlais, 2016, Integrated respondent-driven sampling and peer support for persons who inject drugs in Haiphong, Vietnam: A case study with implications for interventions, Aids Care, 28, 1312, 10.1080/09540121.2016.1178698 Des Jarlais, 2011, HIV among drug users at Beth Israel Medical Center, New York City, the first 25 years, Substance Use and Misuse, 46, 131, 10.3109/10826084.2011.521456 Des Jarlais, 1995, Maintaining low HIV seroprevalence in populations of injecting drug users, Journal of the American Medical Association, 274, 1226, 10.1001/jama.1995.03530150050033 Dowling-Guyer, 1994, Reliability of drug users’ self-reported HIV risk behaviors and validity of self-reported recent drug use, Assessment, 1, 383, 10.1177/107319119400100407 Ebright, 2002, Skin and soft tissue infectious in injection drug users, Infectious Disease Clinics of North America, 16, 697, 10.1016/S0891-5520(02)00017-X Epele, 2001, Scars, harm and pain, Journal of Ethnicity in Substance Abuse, 1, 47, 10.1300/J233v01n01_04 Fairbairn, 2010, Social structural factors that shape assisted injecting practices among injection drug users in Vancouver, Canada: A qualitative study, Harm Reduction Journal, 7, 20, 10.1186/1477-7517-7-20 Fairbairn, 2006, Risk profile of individuals who provide assistance with illicit drug injection, Drug and Alcohol Dependence, 82, 41, 10.1016/j.drugalcdep.2005.08.007 Fast, 2008, The perspectives of injection drug users regarding safer injecting education delivered through a supervised injecting facility, Harm Reduction Journal, 5, 32, 10.1186/1477-7517-5-32 Friedman, 2002, Drug-scene roles and HIV risk among Puerto Rican injection drug users in East Harlem, New York and Bayaman, Puerto Rico, Journal of Psychoactive Drugs, 34, 363, 10.1080/02791072.2002.10399977 Gagnon, 2017, It’s time to allow assisted injection in supervised injection sites, CMAJ, 189, E1083, 10.1503/cmaj.170659 Global Commission on Drug Policy, 2017 Gonzales, 2010, The methamphetamine problem in the United States, Annual Review of Public Health, 31, 385, 10.1146/annurev.publhealth.012809.103600 Harris, 2013, Injecting practices in sexual partnerships: Hepatitis C transmission potentials in a ‘risk equivalence’ framework, Drug and Alcohol Dependence, 132, 617, 10.1016/j.drugalcdep.2013.04.012 Hoda, 2008, Prevalence and correlates of jugular injections among injection drug users, Drug and Alcohol Review, 27, 442, 10.1080/09595230802089701 Kerr, 2017, Supervised injection facilities in Canada: Past, present, and future, Harm Reduction Journal, 14, 28, 10.1186/s12954-017-0154-1 Kerr, 2005, A description of a peer-run supervised injection site for injection drug users, Journal of Urban Health, 82, 267, 10.1093/jurban/jti050 Khan, 2013, Non-injection and injection drug use and STI/HIV risk in the United States: The degree to which sexual risk behaviors versus sex with an STI-infected partner account for infection transmission among drug users, AIDS and Behavior, 17, 1185, 10.1007/s10461-012-0276-0 Kimber, 2005, Survey of drug consumption rooms: Service delivery and perceived public health and amenity impact, Drug and Alcohol Review, 24, 21, 10.1080/09595230500125047 Kral, 1998, HIV seroprevalence among street-recruited injection drug and crack cocaine users in 16 US municipalities, American Journal of Public Health, 88, 108, 10.2105/AJPH.88.1.108 Kral, 1999, Risk factors among IDUs who give injections to or receive injections from other drug users, Addiction, 94, 675, 10.1046/j.1360-0443.1999.9456755.x Kral, 2010, Comparing respondent-driven sampling and targeted sampling methods of recruiting injection drug users in San Francisco, Journal of Urban Health, 87, 839, 10.1007/s11524-010-9486-9 Lappalainen, 2015, Decreasing impact of requiring assistance injecting on HIV incidence, Journal of Acquired Immune Deficiency Syndromes, 69, e40, 10.1097/QAI.0000000000000554 Lee, 2013, Assisted injection among people who inject drugs in Thailand, Substance Abuse Treatment, Prevention, and Policy, 8, 32, 10.1186/1747-597X-8-32 Lloyd-Smith, 2008, Risk factors for developing a cutaneous injection-related infection among injection drug users: A cohort study, BMC Public Health, 8, 405, 10.1186/1471-2458-8-405 Lopez, 2013, Interdisciplinary mixed methods research with structurally vulnerable populations: Case studies of injection drug users in San Francisco, International Journal on Drug Policy, 24, 101, 10.1016/j.drugpo.2012.12.004 Mackesy-Amiti, 2012, Prevalence of psychiatric disorders among young injection drug users, Drug And Alcohol Dependence, 124, 70, 10.1016/j.drugalcdep.2011.12.012 Mathers, 2013, Mortality among people who inject drugs: A systematic review and meta-analysis, Bulletin of the World Health Organization, 91, 102, 10.2471/BLT.12.108282 Mathers, 2008, Global epidemiology of injecting drug use and HIV among people who inject drugs: A systematic review, Lancet, 372, 1733, 10.1016/S0140-6736(08)61311-2 McElrath, 2013, Peer injecting: Implications for injecting order and bloodborne viruses among men and women who inject heroin, Journal of Substance Use, 18, 31, 10.3109/14659891.2012.716901 Miller, 2002, Opportunities for prevention: Hepatitis C prevalence and incidence in a cohort of young injection drug users, Hepatology, 36, 737, 10.1053/jhep.2002.35065 Mizuno, 2015, Syndemic vulnerability, sexual and injection risk behaviors, and HIV continuum of care outcomes in HIV-positive injection drug users, AIDS and Behavior, 19, 684, 10.1007/s10461-014-0890-0 Murphy, 1991, ’Kickin’ down to the street doc: Shooting galleries in the San Francisco Bay Area, Contemporary Drug Problems, 18, 9 Needle, 1995, Reliability of self-reported HIV risk behaviors of drug users, Psychology of Addictive Behaviors, 9, 242, 10.1037/0893-164X.9.4.242 Nelson, 2011, Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: Results of systematic reviews, Lancet, 378, 571, 10.1016/S0140-6736(11)61097-0 O’Connell, 2005, Requiring help injecting independently predicts incident HIV infection among injection drug users, Journal of Acquired Immune Deficiency Syndromes, 40, 83, 10.1097/01.qai.0000157006.28535.mL Parkin, 2009, Informal ‘Sorter’ houses: A qualitative insight of the ‘shooting gallery’ phenomenon in a UK setting, Health & Place, 15, 981, 10.1016/j.healthplace.2009.03.004 Pedersen, 2016, Declining trends in the rates of assisted injecting: A prospective cohort study, Harm Reduction Journal, 13 Rafful, 2015, Prevalence and correlates of neck injection among people who inject drugs in Tijuana, Mexico, Drug and Alcohol Review, 34, 630, 10.1111/dar.12264 Rhodes, 2006, Public injecting and the need for ‘safer environment interventions’ in the reduction of drug-related harm, Addiction, 101, 1384, 10.1111/j.1360-0443.2006.01556.x Robertson, 2010, Correlates of seeking injection assistance among injection drug users in Tijuana, Mexico, American Journal on Addictions, 19, 357 Roux, 2016, Increased uptake of HCV testing through a community-based educational intervention in difficult-to-reach people who inject drugs: Results from the ANRS-AERLI study, PLoS One, 11, e0157062, 10.1371/journal.pone.0157062 Singer, 2003, Syndemics and public health: Reconceptualizing disease in bio-social context, Medical Anthropology Quarterly, 17, 423, 10.1525/maq.2003.17.4.423 Small, 2012, The injection support team: A peer-driven program to address unsafe injecting in a Canadian setting, Substance Use and Misuse, 47, 491, 10.3109/10826084.2012.644107 Spittal, 2002, Risk factors for elevated HIV incidence rates among female injection drug users in Vancouver, CMAJ, 166, 894 Ti, 2015, Contextual factors associated with rushed injecting among people who inject drugs in Thailand, Prevention Science, 16, 313, 10.1007/s11121-014-0477-z Van Den Berg, 2007, Full participation in harm reduction programmes is associated with decreased risk for human immunodeficiency virus and hepatitis C virus: Evidence from the Amsterdam Cohort Studies among drug users, Addiction, 102, 1454, 10.1111/j.1360-0443.2007.01912.x Watters, 1989, Targeted sampling: Options for the study of hidden populations, Social Problems, 36, 416, 10.2307/800824 Weatherby, 1994, Validity of self-reported drug use among injection drug users recruited through street outreach, Evaluation and Program Planning, 17, 347, 10.1016/0149-7189(94)90035-3 Wheeler, 2015, Opioid overdose prevention programs providing naloxone to laypersons—United States, 2014, MMWR Morbidity and Mortality Weekly Report, 64, 631 Wood, 2001, Unsafe injection practices in a cohort of injection drug users in Vancouver: Could safer injecting rooms help?, Canadian Medical Association Journal, 165, 405 Wood, 2008, Nurse-delivered safer injection education among a cohort of injection drug users: Evidence from the evaluation of Vancouver’s supervised injection facility, International Journal of Drug Policy, 19, 183, 10.1016/j.drugpo.2008.01.003 Wood, 2003, An external evaluation of a peer-run “unsanctioned” syringe exchange program, Journal of Urban Health, 80, 455, 10.1093/jurban/jtg052 Wood, 2003, Requiring help injecting as a risk factor for HIV infection in the Vancouver epidemic: Implications for HIV prevention, Canadian Journal of Public Health, 94, 355, 10.1007/BF03403560 Zibbell, 2015, Increases in hepatitis C virus infection related to injection drug use among persons aged <30 years—Kentucky, Tennessee, Virginia, and West Virginia, 2006–2012, Morbidity and Mortality Weekly Report: MMWR, 64, 453 Zibbell, 2017, Increases in acute hepatitis C virus infection related to a growing opioid epidemic and associated injection drug use, United States, 2004 to 2014, American Journal of Public Health, e1